Stay updated on Adjuvant Pembrolizumab in Esophageal Cancer Clinical Trial

Sign up to get notified when there's something new on the Adjuvant Pembrolizumab in Esophageal Cancer Clinical Trial page.
Latest website image capture
Clouds background image

Latest updates to the Adjuvant Pembrolizumab in Esophageal Cancer Clinical Trial page

  1. Check
    2 days ago
    No Change Detected
  2. Check
    9 days ago
    No Change Detected
  3. Check
    16 days ago
    No Change Detected
  4. Check
    23 days ago
    Change Detected
    Summary
    The page has removed a notice regarding heavy traffic affecting the performance and availability of some NLM-NCBI services and products.
    Difference
    1%
    Check dated 2025-02-24T23:01:23.000Z thumbnail image
  5. Check
    30 days ago
    No Change Detected
  6. Check
    38 days ago
    Change Detected
    Summary
    The web page now includes a notice about heavy traffic affecting the performance and availability of some NLM-NCBI services and products, along with contact information for assistance.
    Difference
    1%
    Check dated 2025-02-10T16:30:07.000Z thumbnail image
  7. Check
    45 days ago
    Change Detected
    Summary
    The website has been updated from version v2.14.1 to v2.14.2.
    Difference
    0.1%
    Check dated 2025-02-03T11:46:14.000Z thumbnail image
  8. Check
    59 days ago
    Change Detected
    Summary
    The website has been updated from version 2.14.0 to 2.14.1.
    Difference
    0.1%
    Check dated 2025-01-20T04:10:22.000Z thumbnail image
  9. Check
    66 days ago
    Change Detected
    Summary
    The website has updated the 'type of intervention' feature from version v2.13.3 to v2.14.0, indicating a significant revision.
    Difference
    0.2%
    Check dated 2025-01-12T23:26:36.000Z thumbnail image
  10. Check
    88 days ago
    Change Detected
    Summary
    The latest updates include the posting of results on December 19, 2024, featuring key metrics such as a 1-year relapse-free survival rate and median overall survival, along with new reporting dates and helpful links, while previous submissions and details regarding recurrence detection methods have been removed.
    Difference
    10%
    Check dated 2024-12-22T08:11:36.000Z thumbnail image

Stay in the know with updates to Adjuvant Pembrolizumab in Esophageal Cancer Clinical Trial

Enter your email address, and we'll notify you when there's something new on the Adjuvant Pembrolizumab in Esophageal Cancer Clinical Trial page.